BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 95.75 USD -2.45% Market Closed
Market Cap: 23B USD

Wall Street
Price Targets

BNTX Price Targets Summary
BioNTech SE

Wall Street analysts forecast BNTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNTX is 139.26 USD with a low forecast of 82.93 USD and a high forecast of 194.25 USD.

Lowest
Price Target
82.93 USD
13% Downside
Average
Price Target
139.26 USD
45% Upside
Highest
Price Target
194.25 USD
103% Upside
BioNTech SE Competitors:
Price Targets
XNCR
Xencor Inc
171% Upside
145020
Hugel Inc
50% Upside
ZNTL
Zentalis Pharmaceuticals Inc
344% Upside
AMRN
Amarin Corporation PLC
23% Downside
CVAC
CureVac NV
8% Downside
300676
BGI Genomics Co Ltd
15% Upside
4974
Takara Bio Inc
16% Upside
RCUS
Arcus Biosciences Inc
142% Upside

Revenue
Forecast

Revenue Estimate
BioNTech SE

For the last 6 years the compound annual growth rate for BioNTech SE's revenue is 67%. The projected CAGR for the next 3 years is -2%.

67%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
BioNTech SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
BioNTech SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNTX's stock price target?
Price Target
139.26 USD

According to Wall Street analysts, the average 1-year price target for BNTX is 139.26 USD with a low forecast of 82.93 USD and a high forecast of 194.25 USD.

What is BioNTech SE's Revenue forecast?
Projected CAGR
-2%

For the last 6 years the compound annual growth rate for BioNTech SE's revenue is 67%. The projected CAGR for the next 3 years is -2%.

Back to Top